Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10109-2-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10109-2-AP, RRID:AB_2089700
- Product name
- DAB2 antibody
- Antibody type
- Polyclonal
- Description
- DAB2 antibody (Cat. #10109-2-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: FC, IF, IHC, IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Proper E-cadherin membrane location in colon requires Dab2 and it modifies by inflammation and cancer.
FGFR1-mediated protocadherin-15 loading mediates cargo specificity during intraflagellar transport in inner ear hair-cell kinocilia.
MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2.
Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancer.
Vazquez-Carretero MD, García-Miranda P, Balda MS, Matter K, Ilundáin AA, Peral MJ
Journal of cellular physiology 2021 Feb;236(2):1083-1093
Journal of cellular physiology 2021 Feb;236(2):1083-1093
FGFR1-mediated protocadherin-15 loading mediates cargo specificity during intraflagellar transport in inner ear hair-cell kinocilia.
Honda A, Kita T, Seshadri SV, Misaki K, Ahmed Z, Ladbury JE, Richardson GP, Yonemura S, Ladher RK
Proceedings of the National Academy of Sciences of the United States of America 2018 Aug 14;115(33):8388-8393
Proceedings of the National Academy of Sciences of the United States of America 2018 Aug 14;115(33):8388-8393
MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2.
Xu YF, Mao YP, Li YQ, Ren XY, He QM, Tang XR, Sun Y, Liu N, Ma J
Cancer letters 2015 Jul 28;363(2):146-55
Cancer letters 2015 Jul 28;363(2):146-55
Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancer.
Mhawech-Fauceglia P, Kesterson J, Wang D, Akers S, DuPont NC, Clark K, Lele S, Liu S
Histopathology 2011 Jul;59(1):63-72
Histopathology 2011 Jul;59(1):63-72
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HeLa cells were subjected to SDS PAGE followed by western blot with 10109-2-AP(DAB2 antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of HepG2 cells, using DAB2 antibody 10109-2-AP at 1:50 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).
- Sample type
- cell line
